Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Assess the pros and cons of emergency versus sinking funds to determine which is more suitable for your goals, and how to combine them effectively.
23,832 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As India intensifies crypto oversight, the local premium for USDT widens to 8.5%, forcing rupee buyers into costlier ...
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
As market conditions shift in 2026, smart strategies investors with multimillion-dollar portfolios are leaning into p...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Nearly 1,700 investors binance have filed a London High Court claim against Binance and founder Changpeng Zhao, accus...
Analysts on Wall Street continue lifting price targets for AMD as AI-enabled datacenters drive revenue growth and exp...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
New Zealand housing cools as prices fall again, yet only wealthy buyers can cross the border. For americans escaping ...
The 5-year roth clock: pull rules can turn a tax-free retirement fund into a taxable one if you tap earnings too soon...
The Bank of England’s digital pound project has collided with political finance scrutiny, turning a tech plan into a ...